Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_26243 | 7282 | 151.70 | Mlig455_058373 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.861 Region-enriched R2: 2.532/0.00002 |
PPIB | Mlig455_058373 {REF} {Length: 1101} {Pfam: Cyclophilin type peptidyl-prolyl cis-trans isomerase/CLD [PF00160.23, score=123.3]} {Human: ENSG00000166794, PPIB, peptidylprolyl isomerase B, [Score=154, Expect=2e-47]} {Mouse: ENSMUSG00000032383, Ppib, peptidylprolyl isomerase B, [Score=153, Expect=4e-47]} {Dmel: FBgn0034753, CG2852, [Score=131, Expect=6e-39]} {Celegans: WBGene00000882, cyn-6, Peptidyl-prolyl cis-trans isomerase 6, [Score=139, Expect=4e-42]} {Smed: dd_Smed_v6_348_0_1, dd_Smed_v6_348_0_1, [Score=233, Expect=6e-79]} {RNA1509_11405, RNA1509_2163} {RNA1310_10180, RNA1509_11405} {RNA1509_11405, RNA815_2338.1} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 1.117 | 7.231 | 0.08974 | 0.64430 | |
RegionR2 | 2.532 | 7.231 | 0.00000 | 0.00002 | |
RegionR3 | 1.185 | 7.231 | 0.00584 | 0.10599 | |
RegionR4 | 0.018 | 7.231 | 0.97400 | 1.00000 | |
RegionR5 | -1.656 | 7.231 | 0.00166 | 0.01512 | |
RegionR6 | -1.989 | 7.231 | 0.00029 | 0.01657 | |
RegionR7 | -1.518 | 7.231 | 0.01274 | 0.19910 | |
RegionR8 | 0.311 | 7.231 | 0.53925 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.236 | 7.231 | 0.76184 | 1.00000 | |
RegenerationR2 | -1.386 | 7.231 | 0.02319 | 0.25024 | |
RegenerationR3 | 0.037 | 7.231 | 0.95749 | 1.00000 | |
RegenerationR4 | 0.203 | 7.231 | 0.73707 | 0.96674 | |
RegenerationR5 | 1.075 | 7.231 | 0.07666 | 0.43263 | |
RegenerationR6 | 1.322 | 7.231 | 0.03548 | 0.23603 | |
RegenerationBL | -0.268 | 7.231 | 0.63384 | 0.97406 | |
RegenerationTP | 0.096 | 7.231 | 0.87252 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_26243 | 7282 | 151.7 | Mlig455_058373 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.861 Region-enriched R2: 2.532/0.00002 |
PPIB | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_058373 {REF} {Length: 1101} {Pfam: Cyclophilin type peptidyl-prolyl cis-trans isomerase/CLD [PF00160.23, score=123.3]} {Human: ENSG00000166794, PPIB, peptidylprolyl isomerase B, [Score=154, Expect=2e-47]} {Mouse: ENSMUSG00000032383, Ppib, peptidylprolyl isomerase B, [Score=153, Expect=4e-47]} {Dmel: FBgn0034753, CG2852, [Score=131, Expect=6e-39]} {Celegans: WBGene00000882, cyn-6, Peptidyl-prolyl cis-trans isomerase 6, [Score=139, Expect=4e-42]} {Smed: dd_Smed_v6_348_0_1, dd_Smed_v6_348_0_1, [Score=233, Expect=6e-79]} {RNA1509_11405, RNA1509_2163} {RNA1310_10180, RNA1509_11405} {RNA1509_11405, RNA815_2338.1} |
2. | MligTC455_26241 | 3854 | 80.28 | Mlig455_035817 | Neo: - Age: logFC(26M/2M)=-0.749 Region-specific R2: 4.185 Region-enriched R2: 2.996/0.00000 |
PPIB | 5.72 | 0.968 | 0.989 | 0.807 | 0.985 | 0.995 | 0.976 | Mlig455_035817 {REF} {Length: 1098} {Pfam: Cyclophilin type peptidyl-prolyl cis-trans isomerase/CLD [PF00160.23, score=143.1]} {Human: ENSG00000166794, PPIB, peptidylprolyl isomerase B, [Score=179, Expect=4e-56]; ENSG00000168938, PPIC, peptidylprolyl isomerase C, [Score=172, Expect=3e-53]} {Mouse: ENSMUSG00000032383, Ppib, peptidylprolyl isomerase B, [Score=178, Expect=9e-56]} {Dmel: FBgn0034753, CG2852, [Score=152, Expect=6e-46]} {Celegans: WBGene00000882, cyn-6, Peptidyl-prolyl cis-trans isomerase 6, [Score=163, Expect=2e-50]} {Smed: dd_Smed_v6_348_0_1, dd_Smed_v6_348_0_1, [RH, Score=289, Expect=7e-100]} {RNA1509_2163} {RNA1310_10180} {RNA815_2338.1} |
3. | MligTC455_29797 | 2469 | 51.44 | Mlig455_011428 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.328 Region-enriched R2: 5.791/0.00000 |
5.225 | 0.973 | 0.916 | 0.707 | 0.867 | 0.957 | 0.805 | Mlig455_011428 {REF} {Length: 902} {RNA1509_21417, RNA1509_23190, RNA1509_31800, RNA1509_3881, RNA1509_41776, RNA1509_43586} {RNA1310_44752, RNA1509_21417, RNA1509_23190, RNA1509_31800, RNA1509_3881, RNA1509_41776, RNA1509_43586} {RNA1509_21417, RNA1509_23190, RNA1509_31800, RNA1509_3881, RNA1509_41776, RNA1509_43586, RNA815_21540} | |
4. | MligTC455_36373 | 2360 | 49.17 | Mlig455_008690 | Neo: - Age: - Region-enriched R2: 7.147/0.00000 |
4.467 | 0.880 | 0.853 | 0.821 | 0.941 | 0.972 | - | Mlig455_008690 {REF} {Length: 1552} {RNA1509_2189} {RNA1310_71597} {RNA815_31926.1} | |
5. | MligTC455_14125 | 432 | 9.01 | Mlig455_031050 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-1.941 Region-specific R2: 7.318 Region-enriched R2: 7.339/0.00000 |
OTOG | 3.663 | 0.782 | 0.920 | - | 0.975 | 0.986 | - | Mlig455_031050 {REF} {Length: 2951} {Pfam: Spondin-like TSP1 domain [PF19028.2, score=32.8]; Pacifastin inhibitor (LCMII) [PF05375.15, score=25.4]} {Human: ENSG00000188162, OTOG, otogelin, [Score=49.3, Expect=6e-06]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=53.9, Expect=1e-07]} {Smed: dd_Smed_v6_628_0_1, dd_Smed_v6_628_0_1, [Score=117, Expect=3e-29]} {RNA1509_2451} {RNA1310_3554.1} {RNA815_1109} |
6. | MligTC455_19280 | 21417 | 446.19 | Mlig455_057387, Mlig455_059547 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.621 Region-enriched R2: 3.570/0.00141 |
CHRNA10 | 3.556 | 0.969 | 0.859 | 0.807 | - | - | 0.921 | Mlig455_057387 {REF} {Length: 1088} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=87.8]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=95.5, Expect=6e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=95.5, Expect=4e-22]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=94.7, Expect=1e-21]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=94.0, Expect=2e-21]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=109, Expect=6e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=120, Expect=8e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=97.4, Expect=5e-23]} {RNA1509_1306, RNA1509_1333, RNA1509_15501} {RNA1310_34970, RNA1509_1333, RNA1509_15501} {RNA1509_1333, RNA1509_15501, RNA815_15305.1} Mlig455_059547 {REF} {Length: 1084} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=85.3]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=91.3, Expect=1e-20]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=92.0, Expect=7e-21]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=88.2, Expect=1e-19]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=110, Expect=2e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=120, Expect=4e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=96.3, Expect=8e-23]} {RNA1509_1306} {RNA1310_34970} {RNA815_15305.1} |
7. | MligTC455_36371 | 1892 | 39.41 | Mlig455_005636 | Neo: - Age: Down-Down-Up Region-enriched R2: 7.119/0.00007 |
C6orf120 | 3.488 | 0.729 | 0.856 | - | 0.937 | 0.966 | - | Mlig455_005636 {REF} {Length: 4589} {TRANSSPLICED} {Pfam: Putative cytokine, C6ORF120 [PF17065.7, score=46.3]} {Human: ENSG00000185127, C6orf120, chromosome 6 open reading frame 120, [Score=52.8, Expect=5e-08]} {Mouse: ENSMUSG00000050088, 1600012H06Rik, RIKEN cDNA 1600012H06 gene, [Score=52.4, Expect=5e-08]} {RNA1509_33302, RNA1509_46654} {RNA1310_15958, RNA1509_46654} {RNA1509_46654, RNA815_10779} |
8. | MligTC455_27334 | 8215 | 171.14 | Mlig455_016712, Mlig455_029695, Mlig455_054619 | Neo: - Age: Down-Up-Down Region-enriched R2: 7.862/0.00000 Regeneration-downregulated R2: -6.166 Regeneration-depleted R2: -6.166 |
GNAI1 | 3.408 | 0.788 | 0.774 | 0.964 | 0.882 | - | - | Mlig455_016712 {REF} {Length: 1973} {Pfam: G-protein alpha subunit [PF00503.22, score=406.7]; ADP-ribosylation factor family [PF00025.23, score=55.8]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=21.9]; Gtr1/RagA G protein conserved region [PF04670.14, score=19.7]} {Human: ENSG00000127955, GNAI1, G protein subunit alpha i1, [Score=484, Expect=3e-171]; ENSG00000114353, GNAI2, G protein subunit alpha i2, [Score=477, Expect=1e-168]; ENSG00000065135, GNAI3, G protein subunit alpha i3, [Score=473, Expect=4e-167]} {Mouse: ENSMUSG00000057614, Gnai1, guanine nucleotide binding protein (G protein), alpha inhibiting 1, [Score=484, Expect=2e-171]; ENSMUSG00000032562, Gnai2, guanine nucleotide binding protein (G protein), alpha inhibiting 2, [Score=480, Expect=4e-170]; ENSMUSG00000000001, Gnai3, guanine nucleotide binding protein (G protein), alpha inhibiting 3, [Score=471, Expect=2e-166]} {Dmel: FBgn0001104, Galphai, G protein alpha i subunit, [Score=469, Expect=1e-165]} {Celegans: WBGene00001648, goa-1, Guanine nucleotide-binding protein G(o) subunit alpha, [Score=439, Expect=6e-154]} {Smed: dd_Smed_v6_12112_0_1, dd_Smed_v6_12112_0_1, [RH, Score=593, Expect=0.0]} {RNA1509_45426} {RNA1310_25155} {RNA815_14897.2} Mlig455_029695 {REF} {Length: 555} {RNA1509_10588, RNA1509_1324, RNA1509_2721, RNA1509_2874, RNA1509_3945, RNA1509_46274} {RNA1310_102625.1, RNA1509_10588, RNA1509_1324, RNA1509_2721, RNA1509_3945, RNA1509_46274} {RNA1509_10588, RNA1509_1324, RNA1509_2721, RNA1509_3945, RNA1509_46274, RNA815_20834} Mlig455_054619 {REF} {Length: 911} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=36.2]} {RNA1509_40708} {RNA1310_26224} {RNA815_14744.1} |
9. | MligTC455_16781 | 32 | 0.67 | Mlig455_003020, Mlig455_003313 | Neo: - Age: - |
3.389 | - | 0.705 | - | 0.923 | 0.960 | 0.801 | Mlig455_003020 {REF} {Length: 518} {Pfam: Immunoreceptor tyrosine-based activation motif [PF02189.17, score=26.8]} {RNA1310_57787} {RNA815_49158} Mlig455_003313 {REF} {Length: 905} {Pfam: Immunoreceptor tyrosine-based activation motif [PF02189.17, score=74.4]} {RNA1310_57787} {RNA815_49158} |
|
10. | MligTC455_43224 | 3195 | 66.56 | Mlig455_035023, Mlig455_053445 | Neo: - Age: logFC(26M/2M)=-1.026 Region-enriched R2: 9.114/0.00000 |
ELSPBP1 | 2.931 | - | 0.969 | - | 0.981 | 0.981 | - | Mlig455_035023 {REF} {Length: 1139} {Pfam: Fibronectin type II domain [PF00040.21, score=74.2]; Calcium-binding EGF domain [PF07645.17, score=23.1]} {Human: ENSG00000169393, ELSPBP1, epididymal sperm binding protein 1, [RH, Score=64.7, Expect=2e-12]} {Mouse: ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [Score=65.9, Expect=6e-12]} {Smed: dd_Smed_v6_1748_0_1, dd_Smed_v6_1748_0_1, [Score=49.7, Expect=8e-07]} {RNA1509_10278} {RNA1310_30498} {RNA815_14035} Mlig455_053445 {REF} {Length: 1153} {Pfam: Fibronectin type II domain [PF00040.21, score=74.7]; Calcium-binding EGF domain [PF07645.17, score=25.5]} {Human: ENSG00000169393, ELSPBP1, epididymal sperm binding protein 1, [RH, Score=64.7, Expect=2e-12]} {Mouse: ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [Score=65.9, Expect=7e-12]} {Smed: dd_Smed_v6_1748_0_1, dd_Smed_v6_1748_0_1, [Score=49.7, Expect=9e-07]} {RNA1509_10278} {RNA1310_30498, RNA1509_10278} {RNA1509_10278, RNA815_14035} |
11. | MligTC455_14126 | 1888 | 39.32 | Mlig455_031057 | Neo: Irradiation Age: Up-Down-Down, logFC(26M/2M)=-1.763 Region-specific R2: 6.685 Region-enriched R2: 8.246/0.00000 Regeneration-downregulated R2: -3.933 Regeneration-depleted R2: -3.933 |
SSPO | 2.853 | - | 0.922 | - | 0.960 | 0.971 | - | Mlig455_031057 {REF} {Length: 3178} {Pfam: Spondin-like TSP1 domain [PF19028.2, score=118.7]; Thrombospondin type 1 domain [PF00090.21, score=76.9]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=46.2]; CCN3 Nov like TSP1 domain [PF19035.2, score=19.7]} {Human: ENSG00000197558, SSPO, SCO-spondin, [Score=115, Expect=2e-25]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=113, Expect=9e-25]} {Dmel: FBgn0026721, fat-spondin, [Score=65.5, Expect=2e-10]} {Celegans: WBGene00006893, spon-1, SPONdin (Extracellular matrix glycoprotein) family, [Score=74.3, Expect=3e-13]} {Smed: dd_Smed_v6_628_0_1, dd_Smed_v6_628_0_1, [RH, Score=487, Expect=3e-156]} {RNA1509_2451} {RNA1310_3554.1} {RNA815_1109} |
12. | MligTC455_38698 | 945 | 19.68 | Mlig455_009780 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.658 Region-enriched R2: 1.739/0.00137 Regeneration-downregulated BL: -2.534 Regeneration-depleted BL: -2.534 |
COLEC10 | 2.792 | - | 0.921 | - | 0.950 | 0.921 | - | Mlig455_009780 {REF} {Length: 1506} {Pfam: Lectin C-type domain [PF00059.23, score=43.5]} {Human: ENSG00000184374, COLEC10, collectin subfamily member 10, [Score=50.4, Expect=2e-07]} {Mouse: ENSMUSG00000038591, Colec10, collectin sub-family member 10, [Score=47.8, Expect=1e-06]} {RNA1509_22697} {RNA1310_23822} {RNA815_11460} |
13. | MligTC455_33071 | 1868 | 38.92 | Mlig455_026398, Mlig455_052608 | Neo: - Age: logFC(26M/2M)=0.243 Region-enriched R7: 1.622/0.00135 |
KCNN2 | 2.775 | - | 0.855 | - | 0.941 | 0.979 | - | Mlig455_026398 {REF} {Length: 4271} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=144.5]; Calmodulin binding domain [PF02888.18, score=76.5]; Ion channel [PF07885.18, score=58.3]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [Score=402, Expect=2e-135]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [Score=402, Expect=1e-133]; ENSG00000105642, KCNN1, potassium calcium-activated channel subfamily N member 1, [Score=396, Expect=1e-133]} {Mouse: ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [Score=405, Expect=1e-134]; ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [Score=403, Expect=9e-136]; ENSMUSG00000111706, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=392, Expect=3e-132]; ENSMUSG00000002908, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=392, Expect=3e-132]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [Score=427, Expect=5e-146]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [Score=338, Expect=5e-110]} {Smed: dd_Smed_v6_13309_0_1, dd_Smed_v6_13309_0_1, [RH, Score=491, Expect=2e-172]} {RNA1509_39770, RNA1509_8469} {RNA1310_12461.1, RNA1509_39770, RNA1509_8469} {RNA1509_39770, RNA1509_8469, RNA815_4092.1} Mlig455_052608 {REF} {Length: 4433} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=144.5]; Calmodulin binding domain [PF02888.18, score=76.5]; Ion channel [PF07885.18, score=58.3]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [Score=402, Expect=2e-135]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [Score=402, Expect=1e-133]; ENSG00000105642, KCNN1, potassium calcium-activated channel subfamily N member 1, [Score=396, Expect=1e-133]} {Mouse: ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [Score=405, Expect=1e-134]; ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [Score=403, Expect=9e-136]; ENSMUSG00000111706, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=392, Expect=3e-132]; ENSMUSG00000002908, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=392, Expect=3e-132]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [Score=427, Expect=5e-146]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [Score=338, Expect=5e-110]} {Smed: dd_Smed_v6_13309_0_1, dd_Smed_v6_13309_0_1, [RH, Score=491, Expect=2e-172]} {RNA1509_57498, RNA1509_8469} {RNA1310_12461.2, RNA1509_57498} {RNA1509_57498, RNA815_4092.1} |
14. | MligTC455_36372 | 925 | 19.28 | Mlig455_005680 | Neo: - Age: logFC(26M/2M)=2.101 Region-enriched R2: 7.233/0.00006 |
2.775 | - | 0.855 | - | 0.954 | 0.966 | - | Mlig455_005680 {REF} {Length: 1993} {RNA1509_18409, RNA1509_31432} {RNA1310_82233, RNA1509_18409, RNA1509_31432} {RNA1509_18409, RNA1509_31432, RNA815_42934} | |
15. | MligTC455_48790 | 413 | 8.61 | Mlig455_011702 | Neo: - Age: logFC(26M/2M)=-0.552 Region-enriched R2: 1.934/0.02894 |
2.688 | - | 0.837 | - | 0.892 | 0.959 | - | Mlig455_011702 {REF} {Length: 1287} {RNA1509_23745, RNA1509_59166} {RNA1310_26794.1, RNA1509_23745, RNA1509_59166} {RNA1509_23745, RNA1509_59166, RNA815_13204} | |
16. | MligTC455_33072 | 230 | 4.8 | Mlig455_052654 | Neo: - Age: - Region-enriched R3: 2.742/0.03551 |
2.676 | - | 0.954 | - | 0.870 | 0.852 | - | Mlig455_052654 {REF} {Length: 650} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_57498} {RNA1310_24453.3} {RNA815_11507} | |
17. | MligTC455_50927 | 254 | 5.29 | Mlig455_070541, Mlig455_070562 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.296 Region-enriched R2: 7.883/0.00008 |
FZD4 | 2.671 | - | 0.864 | - | 0.955 | - | 0.852 | Mlig455_070541 {REF} {Length: 3522} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=471, Expect=6e-159]} {RNA1509_15834} {RNA1310_3800, RNA1509_15834} {RNA1509_15834, RNA815_19571} Mlig455_070562 {REF} {Length: 3527} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=2e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=470, Expect=8e-159]} {RNA1509_15834} {RNA1310_3800} {RNA815_19571} |
18. | MligTC455_14856 | 14 | 0.29 | Mlig455_023184 | Neo: - Age: - |
ANGPTL7 | 2.648 | - | - | - | 0.827 | 0.951 | 0.870 | Mlig455_023184 {REF} {Length: 1290} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.4]; PAN domain [PF00024.28, score=23.8]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=105, Expect=1e-25]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=103, Expect=3e-24]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=104, Expect=1e-25]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=102, Expect=4e-24]} {Dmel: FBgn0033312, CG8642, [Score=96.7, Expect=2e-22]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=98.6, Expect=5e-23]} {RNA1509_58115} {RNA1310_36699.1} {RNA815_17918.1} |
19. | MligTC455_19180 | 732 | 15.25 | Mlig455_065589 | Neo: - Age: - Region-enriched R8: 1.853/0.01583 |
2.632 | - | 0.717 | - | 0.940 | 0.975 | - | Mlig455_065589 {REF} {Length: 1480} {Smed: dd_Smed_v6_5147_0_1, dd_Smed_v6_5147_0_1, [RH, Score=62.0, Expect=4e-11]} {RNA1509_38428} {RNA1310_38164} {RNA815_17603} | |
20. | MligTC455_17947 | 64 | 1.34 | Mlig455_042563 | Neo: - Age: - Region-enriched R2: 7.054/0.00113 |
ASCL5 | 2.625 | - | 0.973 | - | 0.821 | 0.831 | - | Mlig455_042563 {REF} {Length: 1821} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=52.5]} {Human: ENSG00000232237, ASCL5, achaete-scute family bHLH transcription factor 5, [Score=84.7, Expect=6e-20]} {Mouse: ENSMUSG00000097918, Ascl5, achaete-scute family bHLH transcription factor 5, [Score=84.0, Expect=5e-20]} {Dmel: FBgn0002922, nau, nautilus, [Score=49.3, Expect=6e-07]} {Celegans: WBGene00001952, hlh-6, Helix-loop-helix protein 6, [RH, Score=90.9, Expect=4e-22]} {Smed: dd_Smed_v6_14753_0_1, dd_Smed_v6_14753_0_1, [RH, Score=76.6, Expect=2e-17]} {RNA1310_71187} |
21. | MligTC455_25920 | 378 | 7.87 | Mlig455_006540 | Neo: - |
2.602 | - | 0.803 | 0.965 | 0.834 | - | - | Mlig455_006540 {REF} {Length: 1697} {RNA1509_12380} {RNA1310_42539} {RNA815_19957} | |
22. | MligTC455_29223 | 4140 | 86.24 | Mlig455_049112 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.584 Region-enriched R3: 5.676/0.00000 |
2.599 | 0.736 | - | - | 0.908 | 0.955 | - | Mlig455_049112 {REF} {Length: 1072} {RNA1509_1747} {RNA1310_46172} {RNA815_23439} | |
23. | MligTC455_39781 | 4052 | 84.43 | Mlig455_031206 | Neo: - Age: - Region-specific R2: 2.205 Region-enriched R2: 1.861/0.00000 |
CLVS2 | 2.599 | 0.907 | 0.959 | - | - | - | 0.733 | Mlig455_031206 {REF} {Length: 2771} {Pfam: CRAL/TRIO domain [PF00650.22, score=62.0]} {Human: ENSG00000146352, CLVS2, clavesin 2, [Score=112, Expect=5e-28]; ENSG00000177182, CLVS1, clavesin 1, [Score=112, Expect=9e-28]; ENSG00000124120, TTPAL, alpha tocopherol transfer protein like, [Score=110, Expect=3e-27]} {Mouse: ENSMUSG00000019785, Clvs2, clavesin 2, [Score=112, Expect=4e-28]; ENSMUSG00000041216, Clvs1, clavesin 1, [Score=111, Expect=1e-27]; ENSMUSG00000017679, Ttpal, tocopherol (alpha) transfer protein-like, [Score=110, Expect=3e-27]} {Dmel: FBgn0036289, CG10657, [RH, Score=120, Expect=3e-31]} {Smed: dd_Smed_v6_12402_0_3, dd_Smed_v6_12402_0_3, [RH, Score=241, Expect=7e-78]} {RNA1509_17672, RNA1509_26784, RNA1509_33745, RNA1509_3681, RNA1509_37291, RNA1509_38202} {RNA1310_7594.1, RNA1509_17672, RNA1509_26784, RNA1509_33745, RNA1509_3681, RNA1509_37291, RNA1509_38202} {RNA1509_17672, RNA1509_26784, RNA1509_33745, RNA1509_3681, RNA1509_37291, RNA1509_38202, RNA815_4242.1} |
24. | MligTC455_16872 | 306 | 6.37 | Mlig455_006228 | Neo: - Age: - Region-specific R2: 5.842 Region-enriched R2: 4.577/0.00000 |
2.506 | 0.968 | - | - | 0.734 | - | 0.804 | Mlig455_006228 {REF} {Length: 952} {RNA1310_48111} {RNA815_24753} | |
25. | MligTC455_27025 | 706 | 14.7 | Mlig455_054786, Mlig455_054878 | Neo: - Age: - Region-enriched R2: 3.519/0.00005 |
CD82 | 2.502 | - | 0.954 | - | 0.721 | - | 0.827 | Mlig455_054786 {REF} {Length: 2796} {Pfam: Tetraspanin family [PF00335.22, score=142.8]} {Human: ENSG00000085117, CD82, CD82 molecule, [RH, Score=86.3, Expect=4e-19]} {Mouse: ENSMUSG00000027215, Cd82, CD82 antigen, [RH, Score=94.0, Expect=3e-22]} {Dmel: FBgn0035936, Tsp66E, Tetraspanin 66E, [Score=98.6, Expect=6e-24]} {Celegans: WBGene00006632, tsp-6, Tetraspanin, [Score=74.7, Expect=1e-15]} {Smed: dd_Smed_v6_13639_0_1, dd_Smed_v6_13639_0_1, [RH, Score=160, Expect=2e-47]} {RNA1509_20389, RNA1509_43644, RNA1509_56428} {RNA1310_8032.1, RNA1509_20389, RNA1509_43644, RNA1509_56428} {RNA1509_20389, RNA1509_43644, RNA1509_56428, RNA815_3380.1} Mlig455_054878 {REF} {Length: 4398} {Pfam: Tetraspanin family [PF00335.22, score=143.7]} {Human: ENSG00000085117, CD82, CD82 molecule, [RH, Score=84.7, Expect=2e-18]} {Mouse: ENSMUSG00000027215, Cd82, CD82 antigen, [RH, Score=92.4, Expect=2e-21]} {Dmel: FBgn0035936, Tsp66E, Tetraspanin 66E, [Score=99.8, Expect=4e-24]} {Celegans: WBGene00006643, tsp-17, TetraSPanin family, [RH, Score=73.2, Expect=1e-14]} {Smed: dd_Smed_v6_13639_0_1, dd_Smed_v6_13639_0_1, [RH, Score=160, Expect=2e-47]} {RNA1509_56428} {RNA1310_8032.2} {RNA815_3380.1} |
26. | MligTC455_39748 | 17060 | 355.41 | Mlig455_068905 | Neo: - Age: - Region-enriched R7: 2.255/0.00030 Regeneration-downregulated BL: -3.088 Regeneration-depleted BL: -3.088 |
2.463 | 0.960 | - | 0.742 | 0.761 | - | - | Mlig455_068905 {REF} {Length: 1123} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [Score=52.4, Expect=4e-08]} {Smed: dd_Smed_v6_1902_0_1, dd_Smed_v6_1902_0_1, [RH, Score=47.4, Expect=2e-07]} {RNA1509_13775, RNA1509_15073, RNA1509_16548, RNA1509_23529, RNA1509_549} {RNA1310_55834.1, RNA1509_13775, RNA1509_15073, RNA1509_16548, RNA1509_23529, RNA1509_549} {RNA1509_13775, RNA1509_15073, RNA1509_16548, RNA1509_23529, RNA1509_549, RNA815_29732} | |
27. | MligTC455_41174 | 229 | 4.78 | Mlig455_065231 | Neo: - Age: - Region-enriched R2: 3.572/0.04561 |
2.446 | - | 0.790 | - | 0.953 | - | 0.703 | Mlig455_065231 {REF} {Length: 1217} {Smed: dd_Smed_v6_20909_0_1, dd_Smed_v6_20909_0_1, [RH, Score=89.7, Expect=3e-21]} {RNA1310_30649} {RNA815_19980} | |
28. | MligTC455_14752 | 17 | 0.36 | Mlig455_009102 | Neo: - Age: - |
1.928 | - | - | - | 0.974 | 0.954 | - | Mlig455_009102 {REF} {Length: 1690} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=50.9]; Capsular polysaccharide synthesis protein [PF05704.14, score=18.3]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [Score=89.7, Expect=1e-19]} {RNA1509_4484} {RNA1310_25467} {RNA815_39314} | |
29. | MligTC455_12388 | 25 | 0.52 | Mlig455_000936 | Neo: - Age: - |
SETMAR | 1.92 | - | - | - | 0.979 | 0.941 | - | Mlig455_000936 {REF} {Length: 2242} {Pfam: Transposase (partial DDE domain) [PF01359.20, score=48.4]; DDE superfamily endonuclease [PF13358.8, score=29.0]; Homeodomain-like domain [PF13565.8, score=24.2]; Transposase [PF01498.20, score=21.1]; Winged helix-turn helix [PF13551.8, score=19.9]} {Human: ENSG00000170364, SETMAR, SET domain and mariner transposase fusion gene, [Score=167, Expect=3e-45]} {Smed: dd_Smed_v6_52102_0_1, dd_Smed_v6_52102_0_1, [Score=69.7, Expect=1e-14]} {RNA1310_28836.1} {RNA815_34045} |
30. | MligTC455_49929 | 76 | 1.59 | Mlig455_001249, Mlig455_001253 | Neo: - Age: Down-Up-Up |
1.888 | - | - | - | 0.982 | 0.906 | - | Mlig455_001249 {REF} {Length: 984} {RNA1310_33799.1} {RNA815_47109} Mlig455_001253 {REF} {Length: 1260} {RNA1310_33799.1} {RNA815_45980} |
|
31. | MligTC455_09224 | 21 | 0.43 | Mlig455_038078 | Neo: - Age: - |
1.863 | - | - | - | 0.975 | - | 0.888 | Mlig455_038078 {REF} {Length: 771} {Pfam: PAN domain [PF00024.28, score=28.0]} {RNA1509_46267} {RNA1310_51656} {RNA815_32275.1} | |
32. | MligTC455_48757 | 61 | 1.28 | Mlig455_008828, Mlig455_008932 | Neo: - Age: Up-Down-Up |
DDC | 1.86 | - | - | - | 0.957 | 0.903 | - | Mlig455_008828 {REF} {Length: 2057} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=471.9]} {Human: ENSG00000132437, DDC, dopa decarboxylase, [RH, Score=572, Expect=0.0]} {Mouse: ENSMUSG00000020182, Ddc, dopa decarboxylase, [RH, Score=558, Expect=0.0]} {Dmel: FBgn0000422, Ddc, Dopa decarboxylase, [RH, Score=553, Expect=0.0]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [RH, Score=545, Expect=0.0]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [RH, Score=563, Expect=0.0]} {RNA1310_37174} {RNA815_42090} Mlig455_008932 {REF} {Length: 2145} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=470.1]} {Human: ENSG00000132437, DDC, dopa decarboxylase, [RH, Score=574, Expect=0.0]} {Mouse: ENSMUSG00000020182, Ddc, dopa decarboxylase, [RH, Score=559, Expect=0.0]} {Dmel: FBgn0000422, Ddc, Dopa decarboxylase, [RH, Score=554, Expect=0.0]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [RH, Score=545, Expect=0.0]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [RH, Score=564, Expect=0.0]} {RNA1310_37174} {RNA815_42090} |
33. | MligTC455_17039 | 24 | 0.5 | Mlig455_025016 | Neo: - Age: - |
1.857 | - | - | - | 0.968 | 0.889 | - | Mlig455_025016 {REF} {Length: 2009} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=72.7]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.5]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=18.8]} {Smed: dd_Smed_v6_14726_0_1, dd_Smed_v6_14726_0_1, [RH, Score=209, Expect=1e-63]} {RNA1310_42205} {RNA815_15017} | |
34. | MligTC455_12032 | 92 | 1.91 | Mlig455_044477 | Neo: - Age: - |
KCNIP1 | 1.852 | - | - | - | 0.969 | - | 0.883 | Mlig455_044477 {REF} {Length: 1077} {Pfam: EF hand [PF00036.34, score=60.1]; EF-hand domain [PF13405.8, score=57.2]; EF-hand domain pair [PF13499.8, score=54.7]; EF-hand domain pair [PF13833.8, score=47.2]; EF hand [PF13202.8, score=43.0]} {Human: ENSG00000182132, KCNIP1, potassium voltage-gated channel interacting protein 1, [Score=169, Expect=9e-52]; ENSG00000120049, KCNIP2, potassium voltage-gated channel interacting protein 2, [Score=164, Expect=7e-49]} {Mouse: ENSMUSG00000053519, Kcnip1, Kv channel-interacting protein 1, [Score=170, Expect=2e-52]} {Dmel: FBgn0039380, CG5890, [Score=150, Expect=5e-45]} {Celegans: WBGene00008998, ncs-4, Neuronal Calcium Sensor family, [RH, Score=121, Expect=1e-33]} {Smed: dd_Smed_v6_9727_0_1, dd_Smed_v6_9727_0_1, [Score=163, Expect=6e-50]} {RNA1310_40826} {RNA815_29104} |
35. | MligTC455_15805 | 9 | 0.19 | Mlig455_023117 | Neo: - Age: - |
KCNK18 | 1.829 | - | - | - | 0.961 | 0.868 | - | Mlig455_023117 {REF} {Length: 1703} {Pfam: Ion channel [PF07885.18, score=119.1]} {Human: ENSG00000186795, KCNK18, potassium two pore domain channel subfamily K member 18, [Score=101, Expect=6e-23]; ENSG00000100433, KCNK10, potassium two pore domain channel subfamily K member 10, [Score=96.3, Expect=1e-20]} {Mouse: ENSMUSG00000040901, Kcnk18, potassium channel, subfamily K, member 18, [Score=103, Expect=7e-24]} {Dmel: FBgn0085425, CG34396, [Score=155, Expect=3e-40]} {Celegans: WBGene00010784, twk-48, TWiK family of potassium channels, [Score=155, Expect=1e-42]} {Smed: dd_Smed_v6_17586_0_1, dd_Smed_v6_17586_0_1, [Score=338, Expect=1e-112]} {RNA1310_118169} |
36. | MligTC455_27174 | 7192 | 149.83 | Mlig455_010138 | Neo: - Age: logFC(26M/2M)=-1.319 Region-enriched R2: 6.471/0.00001 |
1.829 | 0.863 | - | - | - | 0.966 | - | Mlig455_010138 {REF} {Length: 639} {RNA1509_18870, RNA1509_20242, RNA1509_3674} {RNA1310_72305, RNA1509_18870, RNA1509_20242, RNA1509_3674} {RNA1509_18870, RNA1509_20242, RNA1509_3674, RNA815_7257.4} | |
37. | MligTC455_15841 | 197 | 4.09 | Mlig455_045803, Mlig455_063182 | Neo: - Age: - |
1.814 | - | - | 0.957 | - | 0.857 | - | Mlig455_045803 {REF} {Length: 763} {RNA1310_103953} {RNA815_42645} Mlig455_063182 {REF} {Length: 773} {RNA1310_103953} {RNA815_42645} |
|
38. | MligTC455_16054 | 25 | 0.52 | Mlig455_031933 | Neo: - Age: - |
1.806 | - | 0.853 | - | - | 0.953 | - | Mlig455_031933 {REF} {Length: 666} {RNA1310_71129.1} {RNA815_34113} | |
39. | MligTC455_44614 | 545 | 11.35 | Mlig455_052863 | Neo: - Age: - Region-enriched R2: 3.641/0.02102 |
1.799 | - | - | 0.837 | 0.962 | - | - | Mlig455_052863 {REF} {Length: 918} {RNA1509_30662} {RNA1310_67855.1} {RNA815_34213.1} | |
40. | MligTC455_12483 | 119 | 2.48 | Mlig455_054794 | Neo: - Age: Up-Down-Down |
FBN1 | 1.779 | - | - | - | 0.807 | 0.972 | - | Mlig455_054794 {REF} {Length: 4896} {Pfam: Calcium-binding EGF domain [PF07645.17, score=32.9]; Complement Clr-like EGF-like [PF12662.9, score=32.7]; von Willebrand factor type D domain [PF00094.27, score=27.7]} {Human: ENSG00000166147, FBN1, fibrillin 1, [Score=81.3, Expect=5e-15]; ENSG00000142449, FBN3, fibrillin 3, [Score=79.3, Expect=2e-14]} {Mouse: ENSMUSG00000027204, Fbn1, fibrillin 1, [Score=79.0, Expect=2e-14]} {Dmel: FBgn0051999, CG31999, [Score=60.1, Expect=6e-09]} {Celegans: WBGene00001403, fbl-1, Fibulin-1, [Score=61.2, Expect=2e-09]} {Smed: dd_Smed_v6_7311_0_1, dd_Smed_v6_7311_0_1, [Score=65.1, Expect=1e-10]} {RNA1509_35545, RNA1509_46557, RNA1509_6367} {RNA1310_702.1, RNA1509_35545, RNA1509_46557, RNA1509_6367} {RNA1509_35545, RNA1509_46557, RNA1509_6367, RNA815_201.1} |
41. | MligTC455_10786 | 15 | 0.32 | Mlig455_018164 | Neo: - Age: - |
1.762 | - | - | - | 0.968 | - | 0.794 | Mlig455_018164 {REF} {Length: 1819} {Pfam: F5/8 type C domain [PF00754.27, score=24.0]} {Smed: dd_Smed_v6_15258_0_1, dd_Smed_v6_15258_0_1, [RH, Score=57.8, Expect=5e-10]} {RNA1310_114361} | |
42. | MligTC455_29224 | 3570 | 74.37 | Mlig455_049141 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.673 Region-enriched R2: 5.907/0.00019 |
1.762 | - | - | - | 0.811 | 0.951 | - | Mlig455_049141 {REF} {Length: 672} {RNA1509_16346} {RNA1310_46172} {RNA815_23439} | |
43. | MligTC455_19660 | 1113 | 23.18 | Mlig455_042835, Mlig455_045853, Mlig455_045869 | Neo: - Age: - Region-enriched R2: 7.811/0.00000 |
CEP164 | 1.731 | - | 0.960 | - | - | - | 0.771 | Mlig455_042835 {REF} {Length: 1693} {Pfam: WW domain [PF00397.28, score=23.4]} {Human: ENSG00000110274, CEP164, centrosomal protein 164, [Score=69.3, Expect=5e-12]} {Mouse: ENSMUSG00000043987, Cep164, centrosomal protein 164, [Score=71.2, Expect=7e-13]} {Smed: dd_Smed_v6_12228_0_1, dd_Smed_v6_12228_0_1, [Score=73.6, Expect=5e-14]} {RNA1310_28636} {RNA815_10722} Mlig455_045853 {REF} {Length: 1697} {Pfam: WW domain [PF00397.28, score=23.4]} {Human: ENSG00000110274, CEP164, centrosomal protein 164, [Score=68.9, Expect=5e-12]} {Mouse: ENSMUSG00000043987, Cep164, centrosomal protein 164, [Score=71.2, Expect=7e-13]} {Smed: dd_Smed_v6_12228_0_1, dd_Smed_v6_12228_0_1, [Score=73.6, Expect=6e-14]} {RNA1310_28636} {RNA815_10722} Mlig455_045869 {REF} {Length: 1704} {Pfam: WW domain [PF00397.28, score=23.4]} {Human: ENSG00000110274, CEP164, centrosomal protein 164, [Score=68.9, Expect=5e-12]} {Mouse: ENSMUSG00000043987, Cep164, centrosomal protein 164, [Score=71.2, Expect=7e-13]} {Smed: dd_Smed_v6_12228_0_1, dd_Smed_v6_12228_0_1, [Score=73.6, Expect=6e-14]} {RNA1310_28636} {RNA815_10722} |
44. | MligTC455_41824 | 194 | 4.03 | Mlig455_048229 | Neo: - Age: - Region-enriched R2: 3.040/0.03860 |
1.712 | 0.760 | - | - | 0.952 | - | - | Mlig455_048229 {REF} {Length: 769} {RNA1509_49797} {RNA1310_60350, RNA1509_49797} {RNA1509_49797, RNA815_30999} | |
45. | MligTC455_23547 | 43 | 0.89 | Mlig455_025198 | Neo: - Age: - |
1.71 | - | 0.742 | - | 0.968 | - | - | Mlig455_025198 {REF} {Length: 1912} {RNA1310_62305} {RNA815_43403} | |
46. | MligTC455_27673 | 123 | 2.56 | Mlig455_041241, Mlig455_053095 | Neo: - Age: Up-Down-Up |
GLRA1, GLRA3 | 1.71 | - | 0.965 | - | 0.745 | - | - | Mlig455_041241 {REF} {Length: 4857} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=165.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=84.7]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=253, Expect=3e-78]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=249, Expect=9e-77]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=246, Expect=1e-75]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=246, Expect=7e-76]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=244, Expect=2e-74]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=243, Expect=1e-74]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=240, Expect=2e-73]} {Dmel: FBgn0024963, GluClalpha, [Score=256, Expect=1e-79]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [RH, Score=247, Expect=6e-76]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [RH, Score=440, Expect=1e-151]} {RNA1509_35986} {RNA1310_28655} {RNA815_20247} Mlig455_053095 {REF} {Length: 4892} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=163.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=83.4]} {Human: ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=254, Expect=9e-79]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=251, Expect=1e-77]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=243, Expect=9e-75]} {Mouse: ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=9e-77]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=244, Expect=5e-75]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=242, Expect=4e-74]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=236, Expect=2e-72]} {Dmel: FBgn0024963, GluClalpha, [Score=257, Expect=4e-80]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=252, Expect=3e-78]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [Score=449, Expect=1e-155]} {RNA1509_54479} {RNA1310_56579} {RNA815_20247} |
47. | MligTC455_24899 | 46 | 0.96 | Mlig455_061325, Mlig455_061327, Mlig455_062677 | Neo: - Age: - Region-enriched R2: 6.235/0.01647 |
1.69 | - | - | - | 0.967 | - | 0.723 | Mlig455_061325 {REF} {Length: 1675} {RNA1310_57697} Mlig455_061327 {REF} {Length: 744} {RNA1310_57697} Mlig455_062677 {REF} {Length: 1745} {RNA1310_57697} |
|
48. | MligTC455_27171 | 6125 | 127.61 | Mlig455_010135 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.929 Region-enriched R3: 5.685/0.00000 |
1.687 | 0.734 | - | - | - | 0.953 | - | Mlig455_010135 {REF} {Length: 854} {Pfam: Domain of unknown function (DUF4576) [PF15144.8, score=20.1]} {RNA1509_25486} {RNA1310_54429.2, RNA1509_25486} {RNA1509_25486, RNA815_7257.4} | |
49. | MligTC455_27172 | 6085 | 126.78 | Mlig455_010168 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-1.970 Region-enriched R3: 5.854/0.00000 |
1.685 | 0.734 | - | - | - | 0.951 | - | Mlig455_010168 {REF} {Length: 844} {RNA1509_14337, RNA1509_21076, RNA1509_6051} {RNA1310_54429.1, RNA1509_14337, RNA1509_21076, RNA1509_6051} {RNA1509_14337, RNA1509_21076, RNA1509_6051, RNA815_23191} | |
50. | MligTC455_18846 | 1132 | 23.58 | Mlig455_006908 | Neo: - Age: - Region-enriched R3: 3.796/0.00000 |
1.673 | - | - | - | - | 0.953 | 0.720 | Mlig455_006908 {REF} {Length: 1145} {RNA1509_16771} {RNA1310_54908.2} {RNA815_21198.1} | |
51. | MligTC455_11160 | 13 | 0.28 | Mlig455_053261, Mlig455_065033 | Neo: - Age: - |
0.983 | - | - | - | 0.983 | - | - | Mlig455_053261 {REF} {Length: 1117} Mlig455_065033 {REF} {Length: 776} |
|
52. | MligTC455_10602 | 7 | 0.14 | Mlig455_069165 | Neo: - Age: - |
0.979 | - | - | - | 0.979 | - | - | Mlig455_069165 {REF} {Length: 609} | |
53. | MligTC455_11071 | 233 | 4.86 | Mlig455_052294 | Neo: - Age: - Region-enriched R7: 3.038/0.02239 |
0.976 | - | 0.976 | - | - | - | - | Mlig455_052294 {REF} {Length: 354} {NoTransDecoderORF} {RNA1310_51357} {RNA815_24712} | |
54. | MligTC455_10787 | 46 | 0.96 | Mlig455_052810 | Neo: - Age: - |
0.971 | - | - | - | 0.971 | - | - | Mlig455_052810 {REF} {Length: 1287} {Pfam: F5/8 type C domain [PF00754.27, score=21.9]} {Smed: dd_Smed_v6_15258_0_1, dd_Smed_v6_15258_0_1, [RH, Score=56.2, Expect=2e-09]} {RNA1509_47815} {RNA1310_114361} {RNA815_11379} | |
55. | MligTC455_46004 | 40 | 0.83 | Mlig455_053399 | Neo: - Age: - |
0.97 | - | - | - | 0.970 | - | - | Mlig455_053399 {REF} {Length: 583} {NoTransDecoderORF} {RNA1310_66147} {RNA815_35487} | |
56. | MligTC455_29725 | 72 | 1.49 | Mlig455_014390 | Neo: - Age: - Region-enriched R2: 7.905/0.00012 |
OTOP2 | 0.968 | - | - | - | 0.968 | - | - | Mlig455_014390 {REF} {Length: 2547} {Pfam: Otopetrin [PF03189.15, score=220.6]} {Human: ENSG00000183034, OTOP2, otopetrin 2, [Score=52.0, Expect=3e-06]; ENSG00000163982, OTOP1, otopetrin 1, [Score=49.7, Expect=1e-05]} {Mouse: ENSMUSG00000051596, Otop1, otopetrin 1, [Score=53.5, Expect=7e-07]; ENSMUSG00000050201, Otop2, otopetrin 2, [Score=51.6, Expect=3e-06]} {Dmel: FBgn0259150, CG42265, [Score=177, Expect=3e-46]} {Celegans: WBGene00017034, otpl-2, OToPetrin-Like, [Score=101, Expect=2e-22]} {Smed: dd_Smed_v6_13612_0_3, dd_Smed_v6_13612_0_3, [Score=276, Expect=7e-84]} {RNA1310_55206} {RNA815_48323} |
57. | MligTC455_32916 | 64 | 1.33 | Mlig455_068908 | Neo: - Age: - |
0.967 | - | - | - | 0.967 | - | - | Mlig455_068908 {REF} {Length: 1572} {RNA1509_32988} {RNA1310_50901} {RNA815_42442} | |
58. | MligTC455_47949 | 48 | 1 | Mlig455_026482, Mlig455_026492 | Neo: - Age: - |
CHRNA3 | 0.962 | - | - | - | 0.962 | - | - | Mlig455_026482 {REF} {Length: 2240} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=248.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=225.1]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=398, Expect=8e-133]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=382, Expect=5e-127]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=382, Expect=2e-126]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=398, Expect=4e-133]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=397, Expect=5e-133]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=384, Expect=1e-127]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=473, Expect=1e-161]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=445, Expect=7e-152]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=416, Expect=2e-140]} {RNA1310_45284} {RNA815_36657} Mlig455_026492 {REF} {Length: 1090} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=248.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=225.1]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=398, Expect=8e-133]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=382, Expect=5e-127]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=382, Expect=2e-126]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=398, Expect=4e-133]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=397, Expect=5e-133]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=384, Expect=1e-127]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=473, Expect=1e-161]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=445, Expect=7e-152]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=416, Expect=2e-140]} {RNA1310_45284} {RNA815_36657} |
59. | MligTC455_29622 | 818 | 17.05 | Mlig455_047251, Mlig455_047304 | Neo: - Age: - Region-enriched R2: 2.325/0.00092 Regeneration-downregulated BL: -4.291 Regeneration-depleted BL: -4.291 |
CALM2 | 0.961 | - | 0.961 | - | - | - | - | Mlig455_047251 {REF} {Length: 2133} {Pfam: EF hand [PF00036.34, score=100.9]; EF-hand domain pair [PF13499.8, score=97.6]; EF-hand domain [PF13405.8, score=82.7]; EF-hand domain pair [PF13833.8, score=77.3]; EF hand [PF13202.8, score=73.6]; EF-hand domain [PF14658.8, score=41.0]; Dockerin type I domain [PF00404.20, score=35.2]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=29.7]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=26.5]; Tellurite resistance protein TerB [PF05099.15, score=20.5]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=127, Expect=3e-36]; ENSG00000198668, CALM1, calmodulin 1, [Score=125, Expect=6e-36]; ENSG00000160014, CALM3, calmodulin 3, [Score=125, Expect=7e-36]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=130, Expect=2e-37]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=125, Expect=5e-36]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=125, Expect=5e-36]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=122, Expect=4e-35]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=122, Expect=3e-35]} {Smed: dd_Smed_v6_12048_0_1, dd_Smed_v6_12048_0_1, [RH, Score=166, Expect=8e-50]} {RNA1509_29426} {RNA1310_21067.1} {RNA815_25363} Mlig455_047304 {REF} {Length: 1449} {Pfam: EF hand [PF00036.34, score=101.1]; EF-hand domain pair [PF13499.8, score=95.2]; EF-hand domain pair [PF13833.8, score=81.2]; EF-hand domain [PF13405.8, score=80.9]; EF hand [PF13202.8, score=73.1]; EF-hand domain [PF14658.8, score=40.8]; Dockerin type I domain [PF00404.20, score=34.9]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=30.2]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=30.0]; Tellurite resistance protein TerB [PF05099.15, score=20.3]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=125, Expect=2e-35]; ENSG00000198668, CALM1, calmodulin 1, [Score=124, Expect=4e-35]; ENSG00000160014, CALM3, calmodulin 3, [Score=123, Expect=4e-35]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=127, Expect=3e-36]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=123, Expect=3e-35]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=123, Expect=3e-35]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=120, Expect=2e-34]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=120, Expect=2e-34]} {Smed: dd_Smed_v6_12048_0_1, dd_Smed_v6_12048_0_1, [RH, Score=162, Expect=6e-48]} {RNA1509_29426} {RNA1310_20874} {RNA815_31458} |
60. | MligTC455_18746 | 23 | 0.47 | Mlig455_024831 | Neo: - Age: - Region-enriched R4: 8.220/0.00001 Regeneration-depleted R4: -6.352 |
0.959 | - | - | - | 0.959 | - | - | Mlig455_024831 {REF} {Length: 1230} {Smed: dd_Smed_v6_500_0_1, dd_Smed_v6_500_0_1, [Score=52.0, Expect=1e-07]} {RNA1509_9302} {RNA1310_672.1} {RNA815_6919} | |
61. | MligTC455_05537 | 3 | 0.06 | Mlig455_033428 | Neo: - Age: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_033428 {REF} {Length: 524} {TRANSSPLICED} {Pfam: Homeodomain-like domain [PF13565.8, score=33.9]; Winged helix-turn helix [PF13551.8, score=26.5]} {RNA1310_101187} | |
62. | MligTC455_46712 | 29 | 0.6 | Mlig455_034008 | Neo: - Age: - |
0.958 | - | 0.958 | - | - | - | - | Mlig455_034008 {REF} {Length: 413} {RNA1509_3272} {RNA1310_44997} {RNA815_30824} | |
63. | MligTC455_47736 | 1775 | 36.98 | Mlig455_054650 | Neo: - Age: logFC(26M/2M)=-0.375 Region-enriched R3: 5.288/0.00000 |
0.958 | - | - | - | - | 0.958 | - | Mlig455_054650 {REF} {Length: 1247} {Pfam: Domain of unknown function (DUF4573) [PF15140.8, score=86.5]} {RNA1509_13769, RNA1509_51431} {RNA1310_40941.1, RNA1509_13769, RNA1509_51431} {RNA1509_13769, RNA1509_51431, RNA815_34286.1} | |
64. | MligTC455_53251 | 67 | 1.4 | Mlig455_018510 | Neo: - Age: logFC(26M/2M)=0.877 Region-enriched R2: 4.210/0.03685 |
SYT7 | 0.957 | - | - | - | 0.957 | - | - | Mlig455_018510 {REF} {Length: 3473} {Pfam: C2 domain [PF00168.32, score=157.9]} {Human: ENSG00000011347, SYT7, synaptotagmin 7, [RH, Score=261, Expect=1e-79]} {Mouse: ENSMUSG00000024743, Syt7, synaptotagmin VII, [RH, Score=251, Expect=2e-77]} {Dmel: FBgn0039900, Syt7, Synaptotagmin 7, [Score=233, Expect=6e-74]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=179, Expect=4e-53]} {Smed: dd_Smed_v6_4222_0_1, dd_Smed_v6_4222_0_1, [Score=194, Expect=1e-57]} {RNA1509_49257} {RNA1310_13701} {RNA815_8339} |
65. | MligTC455_01157 | 3 | 0.07 | Mlig455_018526 | Neo: - Age: - |
0.956 | - | - | - | - | 0.956 | - | Mlig455_018526 {REF} {Length: 119} {NoTransDecoderORF} | |
66. | MligTC455_09115 | 8 | 0.17 | Mlig455_062552 | Neo: - Age: - |
0.956 | - | - | - | - | 0.956 | - | Mlig455_062552 {REF} {Length: 2058} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=143.1]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=57.8, Expect=1e-08]} {Smed: dd_Smed_v6_15195_0_1, dd_Smed_v6_15195_0_1, [Score=52.0, Expect=6e-07]} {RNA1310_85150} {RNA815_45687} | |
67. | MligTC455_53936 | 24 | 0.5 | Mlig455_021898 | Neo: - Age: - |
0.956 | - | - | - | - | 0.956 | - | Mlig455_021898 {REF} {Length: 737} {NoTransDecoderORF} {RNA1310_130902} | |
68. | MligTC455_50781 | 17 | 0.35 | Mlig455_012010 | Neo: - Age: - |
HTR4 | 0.954 | - | - | - | - | 0.954 | - | Mlig455_012010 {REF} {Length: 2944} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=230.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=58.2]; 7tm Chemosensory receptor [PF08395.14, score=19.8]} {Human: ENSG00000164270, HTR4, 5-hydroxytryptamine receptor 4, [RH, Score=219, Expect=4e-67]; ENSG00000184845, DRD1, dopamine receptor D1, [RH, Score=214, Expect=3e-64]} {Mouse: ENSMUSG00000026322, Htr4, 5 hydroxytryptamine (serotonin) receptor 4, [RH, Score=226, Expect=9e-70]} {Dmel: FBgn0038063, Octbeta2R, Octopamine beta2 receptor, [RH, Score=331, Expect=1e-107]} {Celegans: WBGene00001052, dop-1, DOPamine receptor, [Score=181, Expect=9e-53]} {Smed: dd_Smed_v6_13756_0_1, dd_Smed_v6_13756_0_1, [RH, Score=353, Expect=2e-119]} {RNA1310_126774} |
69. | MligTC455_04073 | 3 | 0.07 | Mlig455_005595 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_005595 {REF} {Length: 604} {NoTransDecoderORF} {RNA1509_19566} {RNA1310_121704} {RNA815_49429} | |
70. | MligTC455_05051 | 12 | 0.24 | Mlig455_027802 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_027802 {REF} {Length: 2094} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=43.7]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=23.8]} {Celegans: WBGene00015323, frpr-1, Probable G-protein coupled receptor frpr-1, [Score=53.9, Expect=8e-08]} {Smed: dd_Smed_v6_19397_0_1, dd_Smed_v6_19397_0_1, [Score=89.0, Expect=3e-19]} {RNA1310_29651} {RNA815_43873} | |
71. | MligTC455_10148 | 2 | 0.05 | Mlig455_047545 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_047545 {REF} {Length: 365} {NoTransDecoderORF} {RNA1310_36688} | |
72. | MligTC455_20383 | 6 | 0.13 | Mlig455_032633 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_032633 {REF} {Length: 392} {RNA1509_48296} {RNA1310_86641} {RNA815_40392} | |
73. | MligTC455_41374 | 23 | 0.49 | Mlig455_008163 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_008163 {REF} {Length: 715} {RNA1310_116941} | |
74. | MligTC455_43884 | 6 | 0.12 | Mlig455_044330 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_044330 {REF} {Length: 1140} {Pfam: Presenilin [PF01080.19, score=18.9]; Velvet factor [PF11754.10, score=18.9]} | |
75. | MligTC455_49939 | 28 | 0.58 | Mlig455_010579 | Neo: - Age: - |
GALNT1 | 0.953 | - | - | - | - | 0.953 | - | Mlig455_010579 {REF} {Length: 2403} {Pfam: Glycosyl transferase family 2 [PF00535.28, score=94.3]} {Human: ENSG00000141429, GALNT1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=246, Expect=3e-75]; ENSG00000136542, GALNT5, polypeptide N-acetylgalactosaminyltransferase 5, [Score=245, Expect=8e-72]; ENSG00000144278, GALNT13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=243, Expect=7e-74]; ENSG00000164574, GALNT10, polypeptide N-acetylgalactosaminyltransferase 10, [Score=241, Expect=8e-73]; ENSG00000178234, GALNT11, polypeptide N-acetylgalactosaminyltransferase 11, [Score=238, Expect=2e-71]; ENSG00000115339, GALNT3, polypeptide N-acetylgalactosaminyltransferase 3, [Score=237, Expect=7e-71]} {Mouse: ENSMUSG00000026828, Galnt5, polypeptide N-acetylgalactosaminyltransferase 5, [Score=253, Expect=5e-75]; ENSMUSG00000026994, Galnt3, polypeptide N-acetylgalactosaminyltransferase 3, [Score=250, Expect=5e-76]; ENSMUSG00000000420, Galnt1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=248, Expect=6e-76]; ENSMUSG00000060988, Galnt13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=242, Expect=7e-74]; ENSMUSG00000020520, Galnt10, polypeptide N-acetylgalactosaminyltransferase 10, [Score=241, Expect=7e-73]} {Dmel: FBgn0050463, CG30463, [Score=292, Expect=3e-92]} {Celegans: WBGene00001630, gly-5, Polypeptide N-acetylgalactosaminyltransferase 5, [Score=303, Expect=9e-97]} {Smed: dd_Smed_v6_4615_0_1, dd_Smed_v6_4615_0_1, [Score=339, Expect=7e-111]} {RNA1310_80255} |
76. | MligTC455_17612 | 38 | 0.78 | Mlig455_057835 | Neo: - Age: - |
ADRB2 | 0.952 | - | - | - | 0.952 | - | - | Mlig455_057835 {REF} {Length: 2257} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=166.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=20.1]} {Human: ENSG00000169252, ADRB2, adrenoceptor beta 2, [Score=118, Expect=1e-28]} {Mouse: ENSMUSG00000045730, Adrb2, adrenergic receptor, beta 2, [Score=118, Expect=6e-29]} {Dmel: FBgn0004841, TkR86C, Tachykinin-like receptor at 86C, [Score=129, Expect=4e-32]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=116, Expect=2e-28]} {Smed: dd_Smed_v6_15854_0_1, dd_Smed_v6_15854_0_1, [RH, Score=229, Expect=1e-70]} {RNA1310_66275} {RNA815_49974} |
77. | MligTC455_47852 | 353 | 7.36 | Mlig455_035401, Mlig455_061039 | Neo: - Age: - |
CALM2 | 0.951 | - | 0.951 | - | - | - | - | Mlig455_035401 {REF} {Length: 3373} {Pfam: EF hand [PF00036.34, score=123.7]; EF-hand domain pair [PF13499.8, score=116.5]; EF-hand domain [PF13405.8, score=97.6]; EF-hand domain pair [PF13833.8, score=94.4]; EF hand [PF13202.8, score=80.0]; EF-hand domain [PF14658.8, score=37.5]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=34.6]; Dockerin type I domain [PF00404.20, score=29.0]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=28.8]; Tellurite resistance protein TerB [PF05099.15, score=28.5]; Caleosin related protein [PF05042.15, score=22.5]; Uncharacterized conserved protein (DUF2267) [PF10025.11, score=20.3]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=199, Expect=4e-65]; ENSG00000160014, CALM3, calmodulin 3, [Score=198, Expect=4e-65]; ENSG00000198668, CALM1, calmodulin 1, [Score=198, Expect=3e-65]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=198, Expect=3e-65]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=198, Expect=3e-65]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=198, Expect=3e-65]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=198, Expect=1e-65]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=198, Expect=1e-65]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=198, Expect=1e-65]} {RNA1509_38582} {RNA1310_34290, RNA1509_38582} {RNA1509_38582, RNA815_9046} Mlig455_061039 {REF} {Length: 2458} {Pfam: EF hand [PF00036.34, score=123.7]; EF-hand domain pair [PF13499.8, score=116.5]; EF-hand domain [PF13405.8, score=97.6]; EF-hand domain pair [PF13833.8, score=94.4]; EF hand [PF13202.8, score=80.0]; EF-hand domain [PF14658.8, score=37.5]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=34.6]; Dockerin type I domain [PF00404.20, score=29.0]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=28.8]; Tellurite resistance protein TerB [PF05099.15, score=28.5]; Caleosin related protein [PF05042.15, score=22.5]; Uncharacterized conserved protein (DUF2267) [PF10025.11, score=20.3]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=199, Expect=4e-65]; ENSG00000160014, CALM3, calmodulin 3, [Score=198, Expect=4e-65]; ENSG00000198668, CALM1, calmodulin 1, [Score=198, Expect=3e-65]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=198, Expect=3e-65]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=198, Expect=3e-65]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=198, Expect=3e-65]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=198, Expect=1e-65]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=198, Expect=1e-65]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=198, Expect=1e-65]} {RNA1509_38582} {RNA1310_34290} {RNA815_9046} |
78. | MligTC455_08281 | 4 | 0.08 | Mlig455_026221 | Neo: - Age: - |
0.95 | - | - | - | - | 0.950 | - | Mlig455_026221 {REF} {Length: 717} {NoTransDecoderORF} {RNA1310_112642} {RNA815_61497} |